In conclusion, our study demonstrates that G. pentaphyllum, especially its main active compounds, quercetin and rhamnazin, may exert therapeutic effects on NSCLC through the modulation of multiple targets, such as MYC, ESR1, and HIF1A. Here, ESR1 is linked to non-small cell lung carcinoma.